staurosporine has been researched along with nvp 231 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bornancin, F; Fabbro, D; Huwiler, A; Japtok, L; Kleuser, B; Pastukhov, O; Pfeilschifter, J; Schwalm, S; Zangemeister-Wittke, U | 1 |
1 other study(ies) available for staurosporine and nvp 231
Article | Year |
---|---|
The ceramide kinase inhibitor NVP-231 inhibits breast and lung cancer cell proliferation by inducing M phase arrest and subsequent cell death.
Topics: Adenocarcinoma; Apoptosis; Benzothiazoles; Blotting, Western; Breast Neoplasms; Bridged-Ring Compounds; Cell Proliferation; Cell Survival; DNA; Enzyme Inhibitors; Flow Cytometry; Humans; Lung Neoplasms; M Phase Cell Cycle Checkpoints; MCF-7 Cells; Phosphotransferases (Alcohol Group Acceptor); Staurosporine; Tumor Stem Cell Assay | 2014 |